Acute Myeloid Leukemia
Levels of Expression of CD34 Epitope Classes Have Prognostic Value
Published in Cancer Weekly, October 22nd, 2002
"The various epitopes of the CD34 molecule have been classified according to their different sensitivities to enzymatic cleavage by neuraminidase, chymopapain and a glycoprotease from Pasteurella haemolytica. Although monoclonal antibodies have been developed that specifically identify these epitopes, few studies have evaluated the distribution and quantitative expression of such epitopes on leukemic blasts," researchers in France report.
In a prospective multicenter study, the scientists, led by M. Maynadie, "examined and quantified the expression of the three classes of CD34 on fresh leukemic blast cells from 300 cases of acute myeloid leukemia (AML). The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-10-22)
More Articles from Cancer Weekly
- Breast Cancer
Gene mutations reviewed - Leukemia Therapy
Cytokine and CD154 gene transfer generate immunity against leukemia - Cancer Vaccines
Cloned T9 cells protect against intracranial glioma tumors - Disease Association
Obesity and weight change increase premenopause breast cancer risk in Hispanic women - Hepatocellular Carcinoma
Doctors predict success in percutaneous ethanol injection for liver cancer - Liver Metastasis
Combining chemotherapy with vessel inhibitors multiplies antitumor effects - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
